39
Participants
Start Date
May 1, 2019
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2024
BroccoMax®
Nutraceutical neoadjuvant
Placebo
control
Shadyside Urology, Pittsburgh
National Cancer Institute (NCI)
NIH
University of Pittsburgh
OTHER